Adiso Therapeutics BD opportunity scan covering pipeline ownership, development stage, evidence package, IP risk, deal precedent and outreach rationale using PatSnap MCP.

Acousia Therapeutics GmbH BD opportunity scan covering pipeline ownership, development stage, evidence package, IP risk, deal precedent and outreach rationale using PatSnap MCP.

Acetylon Pharmaceuticals, Inc. BD opportunity scan covering pipeline ownership, development stage, evidence package, IP risk, deal precedent and outreach rationale using PatSnap MCP.

Abraxis BioScience, Inc BD opportunity scan covering pipeline ownership, development stage, evidence package, IP risk, deal precedent and outreach rationale using PatSnap MCP.

Acer Therapeutics Inc. BD opportunity scan covering pipeline ownership, development stage, evidence package, IP risk, deal precedent and outreach rationale using PatSnap MCP.

Acambis BD opportunity scan covering pipeline ownership, development stage, evidence package, IP risk, deal precedent and outreach rationale using PatSnap MCP.

Acelyrin BD opportunity scan covering pipeline ownership, development stage, evidence package, IP risk, deal precedent and outreach rationale using PatSnap MCP.

Ablynx NV BD opportunity scan covering pipeline ownership, development stage, evidence package, IP risk, deal precedent and outreach rationale using PatSnap MCP.

NCT07735377 clinical trial report covering SHR-6914, Phase 1, endpoints, sponsor, geography, readout timing and development white space.

NCT07735546 clinical trial report covering Sirolimus, Phase 1, endpoints, sponsor, geography, readout timing and development white space.

CTR20262878 clinical trial report covering Progesterone, Phase 1, endpoints, sponsor, geography, readout timing and development white space.

NCT07735728 clinical trial report covering ZE66-0205, Phase 1, endpoints, sponsor, geography, readout timing and development white space.